Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Randomised, Double-Blind, Placebo-Controlled, Multi-centre, Phase III Study of Post-Operative Adjuvant Lapatinib or Placebo and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib or Placebo Monotherapy in High-Risk Subjects With Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)
lapatinib
EGF102988
NCT00424255
Neoplasms, Head and Neck
Phase 3
 
The raw dataset is included within the analysis-ready dataset.
February 2017

Powered by ideaPoint, Inc.